Agnos Therapeutics
PrivateLast Round
VC Round
Jan 29, 2026
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Agnos Therapeutics is a biotechnology company developing mutation-agnostic, iPSC-derived retinal cell therapies to restore vision for patients with inherited blindness.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Agnos Therapeutics Comparables
Compare Agnos Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Opsis Therapeutics | 86% | |
| jCyte, Inc. | 80% | |
| SparingVision | 80% |
Agnos Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| VC Round | Jan 29, 2026 | ||||
| Pre Seed | Jun 10, 2025 | ||||
| Grant | May 14, 2024 |
Agnos Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Johns Hopkins Technology Ventures | Pre Seed |
| Maryland Stem Cell Research Fund | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jan 29, 2026
Completed a VC Round fundraise.
Agnos Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Agnos Therapeutics's valuation, stock price, and market status.
Is Agnos Therapeutics a public or private company?
Agnos Therapeutics is a private company.
What is the current stock price of Agnos Therapeutics?
Agnos Therapeutics is a private company with no public stock price. No recent secondary market data is available.
How much is Agnos Therapeutics worth (valuation)?
Valuation information for Agnos Therapeutics is not publicly available.
Can I buy Agnos Therapeutics stock?
Agnos Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Agnos Therapeutics's last funding round?
Agnos Therapeutics's most recent funding round was VC Round on January 29, 2026.
Who are the main investors in Agnos Therapeutics?
Key investors in Agnos Therapeutics include Johns Hopkins Technology Ventures, Maryland Stem Cell Research Fund.
Will Agnos Therapeutics IPO soon?
No public IPO plans have been announced for Agnos Therapeutics.
How can I track Agnos Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Agnos Therapeutics's secondary market activity and sign up for updates.